| Dr Chad Michael Craig, MD | |
|
3501 Cranberry Blvd, Weston, WI 54476-5213 | |
| (715) 393-1000 | |
| Not Available |
| Full Name | Dr Chad Michael Craig |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 3501 Cranberry Blvd, Weston, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174767867 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 257925 (New York) | Primary |
| Entity Name | New York Society For The Relief Of Ruptured & Crippled Maintaining |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427496652 PECOS PAC ID: 4789818204 Enrollment ID: O20131016000041 |
News Archive
Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.
Halfpenny Technologies, Inc., a leading health information exchange (HIE) company that enables interoperability between physician electronic medical record systems (EMRs) and hospitals, laboratories and other ancillary service providers, today announced that American Pathology Partners, a nationwide, private diagnostic testing services provider based in Nashville, Tenn., will deploy the company's Integration Technology Framework (ITF) platform.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians— says a large number of abstracts – nearly a quarter of the presentations submitted this year to the annual meeting of the American Society of Hematology (ASH) were for myeloma, with one being presented at the prestigious plenary session.
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Chad Michael Craig, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 | Dr Chad Michael Craig, MD 3501 Cranberry Blvd, Weston, WI 54476-5213 Ph: (715) 393-1000 |
News Archive
Children born with certain heart defects have impaired blood flow from the right ventricle to the pulmonary artery leading to the lungs, requiring implanted devices (known as right-ventricular outflow tract conduits) to maintain the flow. However, these conduits fail over time, and children typically face multiple open-heart operations during their lives to reopen the passage.
Halfpenny Technologies, Inc., a leading health information exchange (HIE) company that enables interoperability between physician electronic medical record systems (EMRs) and hospitals, laboratories and other ancillary service providers, today announced that American Pathology Partners, a nationwide, private diagnostic testing services provider based in Nashville, Tenn., will deploy the company's Integration Technology Framework (ITF) platform.
The International Myeloma Foundation (IMF)—supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians— says a large number of abstracts – nearly a quarter of the presentations submitted this year to the annual meeting of the American Society of Hematology (ASH) were for myeloma, with one being presented at the prestigious plenary session.
Eisai announced today that the company received a Complete Response Letter from the United States Food and Drug Administration (FDA) regarding the New Drug Application (NDA) of rabeprazole sodium extended-release capsules, 50 mg, an investigational proton pump inhibitor (PPI) under review for the healing and long-term maintenance of healing and symptom resolution of erosive gastroesophageal reflux disease (GERD), and for the treatment of daytime and nighttime heartburn and other symptoms of non-erosive GERD.
› Verified 4 days ago
Dr. Kshamata Shalini, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Ministry Pkwy, Weston, WI 54476 Phone: 715-393-3000 | |
Matthew Hall, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Cranberry Blvd, Weston, WI 54476 Phone: 715-393-3900 | |
J F Herbert R Macalalad, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 Cranberry Blvd, Weston, WI 54476 Phone: 715-393-1000 | |
Dr. Sanjay Kumar, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3501 Cranberry Blvd, Weston, WI 54476 Phone: 715-393-1000 | |
David A Polomis, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3301 Cranberry Blvd, Weston, WI 54476 Phone: 715-393-3900 | |
Dr. Udaya Shreesha, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Ministry Pkwy, Weston, WI 54476 Phone: 715-393-3000 | |
Keshani Bhushan, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Ministry Pkwy, Weston, WI 54476 Phone: 715-393-3000 |